Correlation Between TRACON Pharmaceuticals and Cellectis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TRACON Pharmaceuticals and Cellectis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TRACON Pharmaceuticals and Cellectis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TRACON Pharmaceuticals and Cellectis SA, you can compare the effects of market volatilities on TRACON Pharmaceuticals and Cellectis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TRACON Pharmaceuticals with a short position of Cellectis. Check out your portfolio center. Please also check ongoing floating volatility patterns of TRACON Pharmaceuticals and Cellectis.

Diversification Opportunities for TRACON Pharmaceuticals and Cellectis

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between TRACON and Cellectis is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding TRACON Pharmaceuticals and Cellectis SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectis SA and TRACON Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TRACON Pharmaceuticals are associated (or correlated) with Cellectis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectis SA has no effect on the direction of TRACON Pharmaceuticals i.e., TRACON Pharmaceuticals and Cellectis go up and down completely randomly.

Pair Corralation between TRACON Pharmaceuticals and Cellectis

If you would invest  125.00  in Cellectis SA on November 4, 2024 and sell it today you would earn a total of  0.00  from holding Cellectis SA or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy5.0%
ValuesDaily Returns

TRACON Pharmaceuticals  vs.  Cellectis SA

 Performance 
       Timeline  
TRACON Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TRACON Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, TRACON Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Cellectis SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectis SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

TRACON Pharmaceuticals and Cellectis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TRACON Pharmaceuticals and Cellectis

The main advantage of trading using opposite TRACON Pharmaceuticals and Cellectis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TRACON Pharmaceuticals position performs unexpectedly, Cellectis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectis will offset losses from the drop in Cellectis' long position.
The idea behind TRACON Pharmaceuticals and Cellectis SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes